Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (11) , 1176-1181
- https://doi.org/10.1016/s0002-9149(00)01198-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatinBMJ, 1997
- The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass GraftsNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention TrialArchives of internal medicine (1960), 1992
- Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.BMJ, 1991
- Cholesterol and MortalityJAMA, 1987